The cold sore treatment market was estimated to be worth USD 825.24 million in 2022, and over the forecast period, a CAGR of 6.6% is anticipated. On the lips or surrounding the mouth, a cold sore develops. One of the main factors contributing to the market's expansion is the increased incidence of HSV infection worldwide.
HSV raises the risk of contracting and spreading HIV infection as well as serious side effects like encephalitis. This is one of the main drivers propelling the market's growth, along with the increasing number of patients with chronic illnesses. The market is expanding as a result of rising healthcare costs and investments in global healthcare infrastructure improvement.

Request For Free Sample Pages @ https://www.xresearch.biz/request-sample-pages/cold-sore-treatment-market

Growth Drivers
The growing prevalence of the herpes simplex virus (HSV) is increasing the need for efficient therapy. Sustained investigation and creation of novel therapeutic alternatives, like topical creams and antiviral drugs, improve patient convenience and effectiveness. The population's growing understanding of the benefits of early treatment and preventive measures drives up demand for over-the-counter medications.
The incidence of breakouts is increased by variables like stress, reduced immunity, and exposure to triggers, which prompts people to look for effective remedies. The industry is growing because customers are prepared to spend money on wellness and healthcare items, which makes a range of treatment alternatives available. Cold sore issues are more common in the elderly population.
The market reach is expanded by the easier purchase experience provided by the increased accessibility of cold sore treatments through online platforms and e-commerce facilities. The market is expanding due to rising demand for antiviral drugs used to treat cold sores. In addition to painkillers, lip balms and lotions are being used more often for therapeutic purposes.
Segmentation
Therapeutics Type
· Antiviral Agents
· Analgesic Agents
· Lysine
· Propolis
· Penciclovir
· Famciclovir
· Rhubarb and Sage
· Acyclovir
· Others
Drug Type
· Branded
· Generics
End-Users
· Home-Care
· Specialty Clinics
· Others
Distribution Channel
· Hospital Pharmacy
· Online Pharmacy
· Retail Pharmacy
· Others
Dosage Form
· Tablet
· Capsule
· Ointment
· Others
Regional Outlook
· Asia Pacific
· North America
· Latin America
· Europe
· Middle East and Africa
Key Players
· Pfizer
· Novartis
· GlaxoSmithKline plc
· Teva Pharmaceuticals Industries ltd.
· Sanofi
· AstraZeneca
· Bayer AG
· Merck. and Co.
· Aurobindo Pharma
· Bausch Health Companies
· Eli Lilly and Company
· Bristol Myers Squibb Company
· Cipla Inc.
· Other Players

For More Information about this Report @ https://www.xresearch.biz/shop/cold-sore-treatment-market

About Us: -
xResearch is a market research and consulting organization that uses unique data, expert analysis, and new technologies to create trusted intelligence on industries. Our research is focused on delivering an informed and impartial view on essential market data of industry, and it is primarily driven by an in-depth study covering the following parameters: Market Sizing and Forecasting, Market Segmentation, Competitive Analysis, Strategic Assessment and Business Modelling.

Contact:
Company Name: xResearch
Contact Person: James Lin
Email: [email protected]
Phone: +1 718-618-4545